2021. Azeliragon ameliorates Alzheimer’s disease via the Janus tyrosine kinase and signal transducer and activator of transcription signaling pathway. Clinics. 76, (Nov. 2021), e2348. DOI:https://doi.org/10.6061/clinics/2021/e2348.